David Malcom Rodman - Net Worth and Insider Trading
David Malcom Rodman Net Worth
The estimated net worth of David Malcom Rodman is at least $2 Million dollars as of 2026-08-13. David Malcom Rodman is the Chief Medical Officer of Mineralys Therapeutics Inc and owns about 51,384 shares of Mineralys Therapeutics Inc (MLYS) stock worth over $1 Million. David Malcom Rodman is also the Exec Vice President and CMO of Alpine Immune Sciences Inc and owns about 2,842 shares of Alpine Immune Sciences Inc (ALPN) stock worth over $184,645. Details can be seen in David Malcom Rodman's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that David Malcom Rodman has not made any transactions after 2026-08-10 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.
Transaction Summary of David Malcom Rodman
David Malcom Rodman Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, David Malcom Rodman owns 2 companies in total, including Alpine Immune Sciences Inc (ALPN) , and Mineralys Therapeutics Inc (MLYS) .
Click here to see the complete history of David Malcom Rodman’s form 4 insider trades.
Insider Ownership Summary of David Malcom Rodman
| Ticker | Company | Transaction Date | Type of Owner |
|---|---|---|---|
| ALPN | Alpine Immune Sciences Inc | 2017-01-04 | See Remarks |
| MLYS | Mineralys Therapeutics Inc | 2026-07-17 | Chief Medical Officer |
David Malcom Rodman Latest Holdings Summary
David Malcom Rodman currently owns a total of 2 stocks. Among these stocks, David Malcom Rodman owns 51,384 shares of Mineralys Therapeutics Inc (MLYS) as of August 10, 2026, with a value of $1 Million and a weighting of 88.28%. David Malcom Rodman also owns 2,842 shares of Alpine Immune Sciences Inc (ALPN) as of January 4, 2017, with a value of $184,645 and a weighting of 11.72%.
Latest Holdings of David Malcom Rodman
| Ticker | Company | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| MLYS | Mineralys Therapeutics Inc | 2026-08-10 | 51,384 | 27.07 | 1,390,965 |
| ALPN | Alpine Immune Sciences Inc | 2017-01-04 | 2,842 | 64.97 | 184,645 |
Holding Weightings of David Malcom Rodman
David Malcom Rodman Form 4 Trading Tracker
According to the SEC Form 4 filings, David Malcom Rodman has made a total of 33 transactions in Mineralys Therapeutics Inc (MLYS) over the past 5 years, including 0 buys and 33 sells. The most-recent trade in Mineralys Therapeutics Inc is the sale of 2,170 shares on August 10, 2026, which brought David Malcom Rodman around $58,785.
According to the SEC Form 4 filings, David Malcom Rodman has made a total of 0 transactions in Alpine Immune Sciences Inc (ALPN) over the past 5 years. The most-recent trade in Alpine Immune Sciences Inc is the sale of 1,672 shares on January 4, 2017, which brought David Malcom Rodman around $15,180.
Insider Trading History of David Malcom Rodman
* The information on this page (including Insider Trading Shares, Share Changes, Cost, etc.) is sourced exclusively from Form 4 filings and does not incorporate any data from 13F or 13D/G filings. As a result, it may differ from the values shown on the Guru page.
- 1
David Malcom Rodman Trading Performance
David Malcom Rodman Ownership Network
Ownership Network List of David Malcom Rodman
Ownership Network Relation of David Malcom Rodman
David Malcom Rodman Owned Company Details
What does Alpine Immune Sciences Inc do?
Who are the key executives at Alpine Immune Sciences Inc?
David Malcom Rodman is the See Remarks of Alpine Immune Sciences Inc. Other key executives at Alpine Immune Sciences Inc include Senior VP and CFO James Paul Rickey , director & Executive Chairman and CEO Mitchell Gold , and director & 10 percent owner Xiangmin Cui .
Alpine Immune Sciences Inc (ALPN) Insider Trades Summary
In summary, during the past 3 months, insiders sold 0 shares of Alpine Immune Sciences Inc (ALPN) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Alpine Immune Sciences Inc (ALPN) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.
Alpine Immune Sciences Inc (ALPN)'s detailed insider trading history can be found in Insider Trading Tracker table.
Alpine Immune Sciences Inc Insider Transactions
David Malcom Rodman Mailing Address
Above is the net worth, insider trading, and ownership report for David Malcom Rodman. Based on the public information released on the U.S. Securities and Exchange Commission (SEC) website, David Malcom Rodman's mailing address is: Radnor Pa 19087.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
